Cargando…

Phaco-goniosynechialysis versus phaco-trabeculectomy in patients with refractory primary angle-closure glaucoma: a comparative study

PURPOSE: To compare the effects of phacoemulsification with intraocular lens implantation (phaco) combined with goniosynechialysis (phaco + GSL) versus phaco with trabeculectomy (phaco + trab) for the management of primary angle-closure glaucoma (PACG) refractory to peripheral anterior synechiae (PA...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Jiahui, Zhang, Chenguang, Pazo, Emmanuel Eric, Dai, Guangzheng, Li, Yunyan, Chen, Yimeng, Li, Mingze, Che, Huixin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080734/
https://www.ncbi.nlm.nih.gov/pubmed/37024836
http://dx.doi.org/10.1186/s12886-023-02885-6
_version_ 1785020977361453056
author Zhao, Jiahui
Zhang, Chenguang
Pazo, Emmanuel Eric
Dai, Guangzheng
Li, Yunyan
Chen, Yimeng
Li, Mingze
Che, Huixin
author_facet Zhao, Jiahui
Zhang, Chenguang
Pazo, Emmanuel Eric
Dai, Guangzheng
Li, Yunyan
Chen, Yimeng
Li, Mingze
Che, Huixin
author_sort Zhao, Jiahui
collection PubMed
description PURPOSE: To compare the effects of phacoemulsification with intraocular lens implantation (phaco) combined with goniosynechialysis (phaco + GSL) versus phaco with trabeculectomy (phaco + trab) for the management of primary angle-closure glaucoma (PACG) refractory to peripheral anterior synechiae (PAS) of over 180°. METHODS: This retrospective study followed 77 eyes of 77 patients for at least 6 months. Intraocular pressure (IOP), best-corrected visual acuity (BCVA), number of glaucoma drugs, and PAS were recorded at the preoperative baseline and evaluated at each postoperative follow-up visit. The National Eye Institute Visual Functioning Questionnaire-25 (NEI VFQ-25) was administered to patients enrolled in this study. Pearson’s correlation analysis and multivariate linear analysis were performed to identify factors influencing changes in NEI VFQ-25 scores and to identify factors associated with increases in NEI VFQ-25 scores after the operation. RESULTS: In total, seventy-seven eyes were included (43 with phaco + GSL and 34 with phaco + trab). Comparing preoperative baseline and month 6 after surgery measurements revealed that both groups found significant improvements in IOP, PAS, BCVA and the number of glaucoma drugs (P < 0.05). Baseline NEI VFQ-25 scores were similar in the two groups, but there was a significant difference in postoperative NEI VFQ-25 scores (74.47 ± 10.39 in phaco + GSL vs. 69.57 ± 8.54 in phaco + trab, P = 0.048 < 0.05), and the phaco + GSL group had better scores at the time of the last follow-up. The change in preoperative scores and the number of glaucoma drugs was significantly correlated with postoperative scores in the phaco + GSL group. CONCLUSION: Phaco + GSL treatment is as safe and effective as phaco + trab for refractory PACG patients, and patients’ subjective experience improved significantly after phaco + GSL surgery.
format Online
Article
Text
id pubmed-10080734
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-100807342023-04-08 Phaco-goniosynechialysis versus phaco-trabeculectomy in patients with refractory primary angle-closure glaucoma: a comparative study Zhao, Jiahui Zhang, Chenguang Pazo, Emmanuel Eric Dai, Guangzheng Li, Yunyan Chen, Yimeng Li, Mingze Che, Huixin BMC Ophthalmol Research PURPOSE: To compare the effects of phacoemulsification with intraocular lens implantation (phaco) combined with goniosynechialysis (phaco + GSL) versus phaco with trabeculectomy (phaco + trab) for the management of primary angle-closure glaucoma (PACG) refractory to peripheral anterior synechiae (PAS) of over 180°. METHODS: This retrospective study followed 77 eyes of 77 patients for at least 6 months. Intraocular pressure (IOP), best-corrected visual acuity (BCVA), number of glaucoma drugs, and PAS were recorded at the preoperative baseline and evaluated at each postoperative follow-up visit. The National Eye Institute Visual Functioning Questionnaire-25 (NEI VFQ-25) was administered to patients enrolled in this study. Pearson’s correlation analysis and multivariate linear analysis were performed to identify factors influencing changes in NEI VFQ-25 scores and to identify factors associated with increases in NEI VFQ-25 scores after the operation. RESULTS: In total, seventy-seven eyes were included (43 with phaco + GSL and 34 with phaco + trab). Comparing preoperative baseline and month 6 after surgery measurements revealed that both groups found significant improvements in IOP, PAS, BCVA and the number of glaucoma drugs (P < 0.05). Baseline NEI VFQ-25 scores were similar in the two groups, but there was a significant difference in postoperative NEI VFQ-25 scores (74.47 ± 10.39 in phaco + GSL vs. 69.57 ± 8.54 in phaco + trab, P = 0.048 < 0.05), and the phaco + GSL group had better scores at the time of the last follow-up. The change in preoperative scores and the number of glaucoma drugs was significantly correlated with postoperative scores in the phaco + GSL group. CONCLUSION: Phaco + GSL treatment is as safe and effective as phaco + trab for refractory PACG patients, and patients’ subjective experience improved significantly after phaco + GSL surgery. BioMed Central 2023-04-06 /pmc/articles/PMC10080734/ /pubmed/37024836 http://dx.doi.org/10.1186/s12886-023-02885-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Zhao, Jiahui
Zhang, Chenguang
Pazo, Emmanuel Eric
Dai, Guangzheng
Li, Yunyan
Chen, Yimeng
Li, Mingze
Che, Huixin
Phaco-goniosynechialysis versus phaco-trabeculectomy in patients with refractory primary angle-closure glaucoma: a comparative study
title Phaco-goniosynechialysis versus phaco-trabeculectomy in patients with refractory primary angle-closure glaucoma: a comparative study
title_full Phaco-goniosynechialysis versus phaco-trabeculectomy in patients with refractory primary angle-closure glaucoma: a comparative study
title_fullStr Phaco-goniosynechialysis versus phaco-trabeculectomy in patients with refractory primary angle-closure glaucoma: a comparative study
title_full_unstemmed Phaco-goniosynechialysis versus phaco-trabeculectomy in patients with refractory primary angle-closure glaucoma: a comparative study
title_short Phaco-goniosynechialysis versus phaco-trabeculectomy in patients with refractory primary angle-closure glaucoma: a comparative study
title_sort phaco-goniosynechialysis versus phaco-trabeculectomy in patients with refractory primary angle-closure glaucoma: a comparative study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080734/
https://www.ncbi.nlm.nih.gov/pubmed/37024836
http://dx.doi.org/10.1186/s12886-023-02885-6
work_keys_str_mv AT zhaojiahui phacogoniosynechialysisversusphacotrabeculectomyinpatientswithrefractoryprimaryangleclosureglaucomaacomparativestudy
AT zhangchenguang phacogoniosynechialysisversusphacotrabeculectomyinpatientswithrefractoryprimaryangleclosureglaucomaacomparativestudy
AT pazoemmanueleric phacogoniosynechialysisversusphacotrabeculectomyinpatientswithrefractoryprimaryangleclosureglaucomaacomparativestudy
AT daiguangzheng phacogoniosynechialysisversusphacotrabeculectomyinpatientswithrefractoryprimaryangleclosureglaucomaacomparativestudy
AT liyunyan phacogoniosynechialysisversusphacotrabeculectomyinpatientswithrefractoryprimaryangleclosureglaucomaacomparativestudy
AT chenyimeng phacogoniosynechialysisversusphacotrabeculectomyinpatientswithrefractoryprimaryangleclosureglaucomaacomparativestudy
AT limingze phacogoniosynechialysisversusphacotrabeculectomyinpatientswithrefractoryprimaryangleclosureglaucomaacomparativestudy
AT chehuixin phacogoniosynechialysisversusphacotrabeculectomyinpatientswithrefractoryprimaryangleclosureglaucomaacomparativestudy